Brought to you by 
ReVision Optics brings in $35mm through its Series E round
20 May 2010
Executive Summary
ReVision Optics Inc. has raised $35mm through the closing of its Series E venture round to 11 undisclosed investors. The company has developed PresbyLens, a miniature lens that is implanted into the cornea to improve vision. The product has the CE Mark and is in clinical trials in the US.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ReVision Optics brings in $35mm through its Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice